Culture of skeletal myoblasts from human donors aged over 40 years: Dynamics of cell growth and expression of differentiation markers

Journal of Translational Medicine

Volumn 3, Issue , 2005, Pages

  Baj, Andreina ^a   Bettaccini, Alessia A ^a   Casalone, Rosario ^a   Sala, Andrea ^a   Cherubino, Paolo ^a   Toniolo, Antonio Q ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Cellular therapy; Heart failure; Human viruses; Karyotype; Stem cells

Indexed keywords

ACTIN; ACTININ; BIOLOGICAL MARKER; DESMIN; DYSTROPHIN; MYOSIN; SPECTRIN;

ADOPTIVE IMMUNOTHERAPY; ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GENE EXPRESSION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; MUSCLE BIOPSY; MUSCLE CELL; MYOBLAST; ORTHOPEDICS; PROTEIN EXPRESSION; SKELETAL MUSCLE; URINARY TRACT DISEASE; VIRUS INFECTION; VIRUS REPLICATION;

EID: 27344451243     PISSN: 14795876     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-3-21     Document Type: Article

References (42)

1. Wollert KC, Drexler H: Cell therapy for acute myocardial infarction: where are we heading? Nature Clin Practice Cardiovascular Med 2004, 1:61.
2. Hawke TJ, Garry DJ: Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 2001, 91:534-551.
3. Chargé SB, Rudnicki MA: Cellular and molecular regulation of muscle regeneration. Physiol Rev 2004, 84:209-238.
4. Schultz E, McCormick KM: Skeletal muscle satellite cells. Rev Physiol Biochem Pharmacol 1994, 123:213-257.
5. Seale P, Sabourin LA, Girgis-Gabardo A, Mansouri A, Gruss P, Rudnicki MA: Pax7 is required for the specification of myogenic satellite cells. Cell 2000, 102:777-786.
6. Lee HJ, Goring W, Ochs M, Muhlfeld C, Steding G, Paprotta I, Engel W, Adham IM: Sox15 is required for skeletal muscle regeneration. Mol Cell Biol 2004, 24:8428-8436.
7. Chen AE, Ginty DD, Fan C-M: Protein kinase A signalling via CREB controls myogenesis induced by Wnt proteins. Nature 2005, 433:317-322.
8. Illa I, Leon-Monzon M, Dalakas MC: Regenerating and denervated human muscle fibers and satellite cells express neural cell adhesion molecule recognized by monoclonal antibodies to natural killer cells. Ann Neural 1992, 31:46-52.
9. Pouzet B, Vilquin JT, Hagege AA, Scorsin M, Messas E, Fiszman M, Schwartz K, Menasche P: Intramyocardial transplantation of autologous myoblasts: can tissue processing be optimized? Circulation 2000:210-215.
10. Agbulut O, Vandervelde S, Al Attar N, Larghero J, Ghostine S, Leobon B, Robidel E, Borsani P, Le Lorc'h M, Bissery A, Chomienne C, Bruneval P, Marolleau JP, Vilquin JT, Hagege A, Samuel JL, Menasché P: Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium. J Am Coll Cardiol 2004, 44:458-463.
11. Siminiak T, Kalawski R, Fiszer D, Jerzykowska O, Rzezniczak J, Rozwadowska N, Kurpisz M: Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Am Heart J 2004, 148:531-537.
12. Fraser JK, Schreiber RE, Zuk PA, Hedrick MH: Adult stem cell therapy for the heart. Int J Biochem Cell Biol 2004, 36:658-666.
13. Leobon B, Garcin I, Menasche P, Vilquin JT, Audinat E, Charpak S: Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A 2003, 100:7808-7811.
14. Menasché P: Skeletal myoblast transplantation for cardiac repair. Expert Rev Cardiovasc Ther 2004, 2:21-28.
15. Pagani FD, DerSimonian H, Zawadzka A, Wetzel K, Edge AS, Jacoby DB, Dinsmore JH, Wright S, Aretz TH, Eisen HJ, Aaronson KD: Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans: Histological analysis of cell survival and differentiation. J Am Coll Cardiol 2003, 41:879-888.
16. Pittenger MF, Martin BJ: Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004, 95:9-20.
17. Pouly J, Hagege AA, Vilquin JT, Bissery A, Rouche A, Bruneval P, Duboc D, Desnos M, Fiszman M, Fromes Y, Menasché P: Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy? Circulation 2004, 110:1626-1631.
18. Yokoyama T, Huard J, Chancellor MB: Myoblast therapy for stress urinary incontinence and bladder dysfunction. World J Urol 2000, 18:56-61.
19. Chermansky C, Huard J, Chancellor MB: Gene therapy using muscle-derived stem cells. In Adult stem cells Edited by: Turksen K. Totowa, NJ: Humana Press; 2004:51-66.
20. Payumo FC, Kim HD, Sherling MA, Smith LP, Powell C, Wang X, Keeping HS, Valentini RF, Vandenburgh HH: Tissue engineering skeletal muscle for orthopaedic applications. Clin Orthop 2002:228-242.
21. Hashimoto N, Murase T, Kondo S, Okuda A, Inagawa-Ogashiwa M: Muscle reconstitution by muscle satellite cell descendants with stem cell-like properties. Development 2004, 131:5481-5490.
22. Chachques JC, Herreros J, Trainini J, Juffe A, Rendal E, Prosper F, Genovese J: Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int J Cardiol 2004:29-33.
23. Wolstenholme J: Human Cytogenetics: a Practical Approach Volume 1. 2nd edition, Edited by: Rooney DE, Czepulkowski BH. Oxford: IRL Press; 1992:1-30.
24. Mitelman F: ISCN: An International System for Human Cytogenetic Nomenclature Basel: S. Karger: 1995.
25. Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH: Manual of Clinical Microbiology Volume 2. 8th edition. Washington, DC: ASM Press: 2003:1253-1604.
26. Penn MS, Zhang M, Deglurkar I, Topol EJ: Role of stem cell homing in myocardial regeneration. Int J Cardiol 2004:23-25.
27. Ghostine S, Carrion C, Souza LC, Richard P, Bruneval P, Vilquin JT, Pouzet B, Schwartz K, Menasché P, Hagege AA: Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 2002:131-136.
28. Murtuza B, Suzuki K, Bou-Gharios G, Beauchamp JR, Smolenski RT, Partridge TA, Yacoub MH: Transplantation of skeletal myoblasts secreting an IL-I inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc Natl Acad Sci U S A 2004, 101:4216-4221.
29. Squadrito F, Deodato B, Squadrito G, Seminara P, Passaniti M, Venuti FS, Giacca M, Minutoli L, Adamo EB, Bellomo M, Marini R, Galeano M, Marini H, Altavilla D: Gene transfer of IkappaBalpha limits infarct size in a mouse model of myocardial ischemia-reper-fusion injury. Lab Invest 2003, 83:1097-1104.
30. Parsa CJ, Matsumoto A, Kim J, Riel RU, Pascal LS, Walton GB, Thompson RB, Petrofski JA, Annex BH, Stamler JS, Koch WJ: A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest 2003, 112:999-1007.
31. Jin H, Wyss JM, Yang R, Schwall R: The therapeutic potential of hepatocyte growth factor for myocardial infarction and heart failure. Curr Pharm Des 2004, 10:2525-2533.
32. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, Pasumarthi KB, Virag JI, Bartelmez SH, Poppa V, Bradford G, Dowell JD, Williams DA, Field LJ: Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004, 428:664-668.
33. Deten A, Volz HC, Clamors S, Leiblein S, Briest W, Marx G, Zimmer HG: Hematopoietic stem cells do not repair the infarcted mouse heart. Cardiovasc Res 2005, 65:52-63.
34. Haider HK, Tan AC, Aziz S, Chachques JC, Sim EK: Myoblast transplantation for cardiac repair: a clinical perspective. Mol Ther 2004, 9:14-23.
35. Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, Abolmaali ND, Vogl TJ, Hofmann WK, Martin H, Dimmeler S, Zeiher AM: Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 2004, 44:1690-1699.
36. Pompilio G, Cannata A, Peccatori F, Bertolini F, Nascimbene A, Capogrossi MC, Biglioli P: Autologous peripheral blood stem cell transplantation for myocardial regeneration: a novel strategy for cell collection and surgical injection. Ann Thorac Surg 2005, 78:1808-1812.
37. Pavlath GK, Gussoni E: Human myoblasts and muscle-derived SP cells. Methods Mol Med 2004, 107:97-110.
38. Baldwin KM, Haddad F: Effects of different activity and inactivity paradigms on myosin heavy chain gene expression in striated muscle. J Appl Physiol 2001, 90:345-357.
39. Andersen JL: Muscle fibre type adaptation in the elderly human muscle. Scand J Med Sci Sports 2003, 13:40-47.
40. Busuttil RA, Dolle M, Campisi J, Vijga J: Genomic instability, aging, and cellular senescence. Ann N Y Acad Sci 2004, 1019:245-255.
41. Foukakis T, Thoppe SR, Lagercrantz S, Dwight T, Weng WH, Svensson A, Hoog A, Zedenius J, Wallin G, Lui WO, Larsson C: Molecular cytogenetic characterization of primary cultures and established cell lines from non-medullary thyroid tumors. Int J Oncol 2005, 26:141-149.
42. Tan K, Guibert C, Neaud V, Rosenbaum J: Hepatitis C virus proteins do not directly trigger fibrogenic events in cultured human liver myofibroblasts. J Viral Hepat 2003, 10:427-432.